Healthcare
Live Price
Offline$0.0763
-4.16% today
Window Change
-71.75%
Window
Jun 30, 2025 โ May 14, 2026
Coverage: 221 bars ยท Jun 30, 2025 โ May 14, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nuvation Bio Inc. (NUVB-WT) is a Healthcare stock with a market cap of $26.15M and listed on NYSE. The stock last traded around $0.08 and down 71.8% across the available one-year price window (Jun 30, 2025 โ May 14, 2026). Baseline metrics include revenue growth of +699.0%, EPS growth of +71.6%, a dividend yield of 0.0%. What stands out right now is revenue +699.0%, EPS +71.6%, free cash flow -33.1% with operating margin -338.7% and ROIC -41.0%. Valuation already assumes a fairly strong business story at price/sales 24.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NUVB-WT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
NUVB-WT is 92.85 pts behind over the shared 1Y window.
NUVB-WT had 83.00 pts deeper max drawdown than SPY.
NUVB-WT beat SPY in 1 of 2 calendar years shown and trailed in 1.
NUVB-WT
-71.75%
Normalized return
SPY
+21.09%
S&P 500
Excess Return
-92.85 pts
Relative to SPY
NUVB-WT Max Drawdown
-92.14%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for NUVB-WT and SPY.
| Year | NUVB-WT | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -75.41% | +6.71% | -82.11 pts | SPY |
| 2025 | +22.27% | +11.19% | +11.07 pts | NUVB-WT |
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
โ
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.